[
    {
        "question_id": "1_B_2052",
        "new_question_id": "8964",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_510",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Obstetric cholestasis",
            "HELLP syndrome",
            "Eclampsia",
            "Gestational hypertension",
            "Acute viral hepatitis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 37 year old woman who is 32 weeks pregnant presents with malaise, headaches and vomiting. She is admitted to the obstetrics ward after a routine blood pressure measurement was 190/95mmHg. Examination reveals right upper quadrant abdominal pain and brisk tendon reflexes. The following blood tests are shown:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>85 g/l</td></tr><tr><td>WBC</td><td>6 * 10<sup>9</sup>/l</td></tr><tr><td>Platelets</td><td>89 * 10<sup>9</sup>/l</td></tr></tbody></table></div><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Bilirubin</td><td>2.8 \u00b5mol/l</td></tr><tr><td>ALP</td><td>215 u/l</td></tr><tr><td>ALT</td><td>260 u/l</td></tr><tr><td>&gamma;GT</td><td>72 u/l</td></tr><tr><td>LDH</td><td>846 u/I</td></tr></tbody></table></div><br />A peripheral blood film is also taken which shows polychromasia and schistocytes.<br /><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "HELLP syndrome is a severe form of pre-eclampsia whose features include: Haemolysis (H), elevated liver enzymes (EL), and low platelets (LP). A typical patient might present with malaise, nausea, vomiting, and headache. Hypertension with proteinuria is a common finding, as well as epigastric and/or upper abdominal pain. <br /><br />The patient in this scenario fulfils the criteria for HELLP syndrome.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 37 year old woman who is 32 weeks pregnant presents with malaise, headaches and vomiting. She is admitted to the obstetrics ward after a routine blood pressure measurement was 190/95mmHg. Examination reveals right upper quadrant abdominal pain and brisk tendon reflexes. The following blood tests are shown:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>85 g/l</td></tr><tr><td>WBC</td><td>6 * 10<sup>9</sup>/l</td></tr><tr><td>Platelets</td><td>89 * 10<sup>9</sup>/l</td></tr></tbody></table></div><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Bilirubin</td><td>2.8 \u00b5mol/l</td></tr><tr><td>ALP</td><td>215 u/l</td></tr><tr><td>ALT</td><td>260 u/l</td></tr><tr><td>&gamma;GT</td><td>72 u/l</td></tr><tr><td>LDH</td><td>846 u/I</td></tr></tbody></table></div><br />A peripheral blood film is also taken which shows polychromasia and schistocytes.<br /><br />What is the most likely diagnosis?",
        "correct_answer": "2",
        "question_notes": "HELLP syndrome is a severe form of pre-eclampsia whose features include: Haemolysis (H), elevated liver enzymes (EL), and low platelets (LP). A typical patient might present with malaise, nausea, vomiting, and headache. Hypertension with proteinuria is a common finding, as well as epigastric and/or upper abdominal pain. <br /><br />The patient in this scenario fulfils the criteria for HELLP syndrome.",
        "answer_order": "2",
        "answer": "2",
        "title": "Pregnancy: jaundice",
        "body": "<h5 class='notes-heading'>Intrahepatic cholestasis of pregnancy</h5><br />Intrahepatic cholestasis of pregnancy (also known as obstetric cholestasis) occurs in around 1% of pregnancies and is generally seen in the third trimester. It is the most common liver disease of pregnancy.<br /><br />Features<br /><ul><li>pruritus, often in the palms and soles</li><li>no rash (although skin changes may be seen due to scratching)</li><li>raised bilirubin</li></ul><br />Management<br /><ul><li>ursodeoxycholic acid is used for symptomatic relief</li><li>weekly liver function tests</li><li>women are typically induced at 37 weeks</li></ul><br />Complications include an increased rate of stillbirth. It is not generally associated with increased maternal morbidity<br /><br /><br /><h5 class='notes-heading'>Acute fatty liver of pregnancy</h5><br />Acute fatty liver of pregnancy is rare complication which may occur in the third trimester or the period immediately following delivery.<br /><br />Features<br /><ul><li>abdominal pain</li><li>nausea & vomiting</li><li>headache</li><li>jaundice</li><li>hypoglycaemia</li><li>severe disease may result in pre-eclampsia</li></ul><br />Investigations<br /><ul><li>ALT is typically elevated e.g. 500 u/l</li></ul><br />Management<br /><ul><li>support care</li><li>once stabilised delivery is the definitive management</li></ul><br /><br />Gilbert's, Dubin-Johnson syndrome, may be exacerbated during pregnancy<br /><br />HELLP<br /><ul><li>Haemolysis, Elevated Liver enzymes, Low Platelets</li></ul>",
        "notes_hash": "e3f0e4877ad548978c147f6536eafed6",
        "knowledge_graph_node_id_link": 10117,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4388",
        "up_votes": "41",
        "down_votes": "4",
        "column_array": [
            0,
            "101",
            "4056",
            "195",
            "15",
            "21",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Canadian Journal of Gastroenterology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_182\" data-linkid=\"182\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_182\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"link_dislike_182\" data-linkid=\"182\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_182\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">9</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538964/\">Acute Fatty Liver of Pregnancy</a></td></tr></table>",
        "media": "",
        "comment_count": 6,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "495_B_2",
        "new_question_id": "7633",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_276",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Arrange for an urgent outpatient CT head",
            "Admit the patient urgently to hospital",
            "Give a prescription for Prochlorperazine and review in 48 hours",
            "Perform a Dix-Hallpike test +/- Epley manoeuvre",
            "Arrange an urgent ECG",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 67-year-old gentleman comes in to your practice complaining of 'dizziness'. He has a past medical history of hypertension, hypercholesterolaemia and hay fever. He is an ex-smoker with a forty pack-year history.<br /><br />On closer questioning, he describes a sudden onset of a sensation at 9am this morning -  'like the room is spinning' - accompanied by nausea but no vomiting. The dizziness has persisted and is constant.<br /><br />On examination he looks well, blood pressure 170/120 mmHg, with other observations in normal range. Cardiac, respiratory and ENT examination is unremarkable. On neurological examination he has normal power, tone, sensation and reflexes throughout both upper and lower limbs bilaterally. There is notable nystagmus on cranial nerve testing. There is also mild past pointing and dysdiadochokinesis.<br /><br />What is the most appropriate action?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "This gentleman has a history suggestive of vascular disease, and has presented with acute onset of symptoms suggesting a posterior stroke. <br /><br />Prochlorperazine may be useful in vestibular neuronitis but given this gentleman's constellation of symptoms, a vascular event is more likely and must be excluded. This should be done urgently and he may need an MRI after a CT head, as MRI is more effective at visualising the posterior part of the brain.<br /><br />Dix-Hallpike is a test for BPPV (Benign Paroxysmal Positional Vertigo) which is episodic and lasts a few seconds at a time, classically by turning the head. The history does not fit with this.<br /><br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 67-year-old gentleman comes in to your practice complaining of 'dizziness'. He has a past medical history of hypertension, hypercholesterolaemia and hay fever. He is an ex-smoker with a forty pack-year history.<br /><br />On closer questioning, he describes a sudden onset of a sensation at 9am this morning -  'like the room is spinning' - accompanied by nausea but no vomiting. The dizziness has persisted and is constant.<br /><br />On examination he looks well, blood pressure 170/120 mmHg, with other observations in normal range. Cardiac, respiratory and ENT examination is unremarkable. On neurological examination he has normal power, tone, sensation and reflexes throughout both upper and lower limbs bilaterally. There is notable nystagmus on cranial nerve testing. There is also mild past pointing and dysdiadochokinesis.<br /><br />What is the most appropriate action?",
        "correct_answer": "2",
        "question_notes": "This gentleman has a history suggestive of vascular disease, and has presented with acute onset of symptoms suggesting a posterior stroke. <br /><br />Prochlorperazine may be useful in vestibular neuronitis but given this gentleman's constellation of symptoms, a vascular event is more likely and must be excluded. This should be done urgently and he may need an MRI after a CT head, as MRI is more effective at visualising the posterior part of the brain.<br /><br />Dix-Hallpike is a test for BPPV (Benign Paroxysmal Positional Vertigo) which is episodic and lasts a few seconds at a time, classically by turning the head. The history does not fit with this.<br /><br />",
        "answer_order": "2",
        "answer": "2",
        "title": "Vertigo",
        "body": "Vertigo may be defined as the <span class=\"concept\" data-cid=\"9551\">false sensation that the body or environment is moving</span>.<br /><br />The table below lists the main characteristics of the most important causes of vertigo<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Disorder</b></th><th><b>Notes</b></th></tr></thead><tbody><tr><td><span class=\"concept\" data-cid=\"9225\"><b>Viral labyrinthitis</b></span></td><td><span class=\"concept\" data-cid=\"9227\">Recent viral infection</span><br /> Sudden onset<br /> Nausea and vomiting<br /> <span class=\"concept\" data-cid=\"1602\">Hearing may be affected</span></td></tr><tr><td><span class=\"concept\" data-cid=\"9226\"><b>Vestibular neuronitis</b></span></td><td>Recent viral infection<br /> Recurrent vertigo attacks lasting hours or days<br /> <span class=\"concept\" data-cid=\"3534\">No hearing loss</span></td></tr><tr><td><b>Benign paroxysmal positional vertigo</b></td><td>Gradual onset<br /> Triggered by change in head position<br /> Each episode lasts 10-20 seconds</td></tr><tr><td><b>Meniere's disease</b></td><td>Associated with hearing loss, tinnitus and sensation of fullness or pressure in one or both ears</td></tr><tr><td><span class=\"concept\" data-cid=\"9228\"><b>Vertebrobasilar ischaemia</b></span></td><td>Elderly patient<br /> Dizziness on extension of neck</td></tr><tr><td><span class=\"concept\" data-cid=\"1603\"><b>Acoustic neuroma</b></span></td><td>Hearing loss, vertigo, tinnitus<br /> Absent corneal reflex is important sign<br /> Associated with neurofibromatosis type 2</td></tr></tbody></table></div><br />Other causes of vertigo include<br /><ul><li><span class=\"concept\" data-cid=\"1466\">posterior circulation stroke</span></li><li>trauma</li><li>multiple sclerosis</li><li>ototoxicity e.g. gentamicin</li></ul>",
        "notes_hash": "9c35391eab2f643a5b52dca32af24711",
        "knowledge_graph_node_id_link": 10189,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6162",
        "up_votes": "53",
        "down_votes": "22",
        "column_array": [
            0,
            "1155",
            "4180",
            "284",
            "513",
            "30",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Patient.info</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1441\" data-linkid=\"1441\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1441\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"link_dislike_1441\" data-linkid=\"1441\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1441\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://patient.info/doctor/vestibular-neuritis-and-labyrinthitis-pro\">Vestibular neuritis and labyrinthitis</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/VwmrjYuvqtQ\" data-description=\"Vertigo maneuvers: Performing the HINTS exam\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"957\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/VwmrjYuvqtQ/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/VwmrjYuvqtQ\" data-description=\"Vertigo maneuvers: Performing the HINTS exam\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"957\">Vertigo maneuvers: Performing the HINTS exam</a></td></tr><tr><td><span ><small>Medmastery - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1656\" data-mediaid=\"1656\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1656\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_1656\" data-mediaid=\"1656\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1656\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1q-VTKPweuk\" data-description=\"The HINTS exam in vertigo\" data-upvotes=\"12\" data-downvotes=\"3\" data-media=\"654\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/1q-VTKPweuk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1q-VTKPweuk\" data-description=\"The HINTS exam in vertigo\" data-upvotes=\"12\" data-downvotes=\"3\" data-media=\"654\">The HINTS exam in vertigo</a></td></tr><tr><td><span ><small>Individual - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1125\" data-mediaid=\"1125\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1125\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"media_dislike_1125\" data-mediaid=\"1125\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1125\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/kx4mQB0QzvQ\" data-description=\"Understanding the Causes of Vertigo\" data-upvotes=\"3\" data-downvotes=\"3\" data-media=\"1042\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/kx4mQB0QzvQ/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/kx4mQB0QzvQ\" data-description=\"Understanding the Causes of Vertigo\" data-upvotes=\"3\" data-downvotes=\"3\" data-media=\"1042\">Understanding the Causes of Vertigo</a></td></tr><tr><td><span ><small>Zero to Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1824\" data-mediaid=\"1824\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1824\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1824\" data-mediaid=\"1824\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1824\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "9225": {
                "concept_text": "Viral labyrinthitis stereotypical history: recently developed an upper respiratory tract infection presents with vertigo and vomiting. Hearing is also affected. The symptoms came on suddenly",
                "concept_percentile": "34"
            },
            "9226": {
                "concept_text": "Vestibular neuritis stereotypical history: recovering from an upper respiratory tract infections presents with recurrent attacks of vertigo associated with nausea and vomiting. There is no hearing loss or tinnitus",
                "concept_percentile": "61"
            },
            "9227": {
                "concept_text": "Recent viral infection, ongoing vertigo and nausea - viral labyrinthitis",
                "concept_percentile": "3"
            },
            "9228": {
                "concept_text": "Elderly patient dizzy on extending neck - vertebrobasilar ischaemia",
                "concept_percentile": "31"
            },
            "9551": {
                "concept_text": "Vertigo is the perception of movement in the absence of movement and requires a clear history to establish its presence",
                "concept_percentile": "35"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1678",
        "new_question_id": "10879",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "6682",
        "notes_id_link": "1_915",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Add amlodipine AND indapamide",
            "Add amlodipine OR bisoprolol",
            "Switch ramipril to losartan",
            "Add amlodipine OR indapamide",
            "Add losartan",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 52-year-old man is seen in the hypertension clinic. He was diagnosed around three months ago and started on ramipril. This has been titrated up to 10mg od but his blood pressure remains around 156/92 mmHg. <br /><br />What is the most appropriate next step in management?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "The 2019 NICE guidelines changed so that if a patient is already taking an ACE-inhibitor or an angiotensin receptor either a calcium channel blocker (e.g. amlodipine) or a thiazide-like diuretic (e.g. indapamide). Previous guidelines suggested that only a calcium channel blocker should be added at this stage.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 52-year-old man is seen in the hypertension clinic. He was diagnosed around three months ago and started on ramipril. This has been titrated up to 10mg od but his blood pressure remains around 156/92 mmHg. <br /><br />What is the most appropriate next step in management?",
        "correct_answer": "4",
        "question_notes": "The 2019 NICE guidelines changed so that if a patient is already taking an ACE-inhibitor or an angiotensin receptor either a calcium channel blocker (e.g. amlodipine) or a thiazide-like diuretic (e.g. indapamide). Previous guidelines suggested that only a calcium channel blocker should be added at this stage.",
        "answer_order": "4",
        "answer": "4",
        "title": "Hypertension: management",
        "body": "NICE published updated guidelines for the management of hypertension in 2019. Some of the key changes include:<br /><ul><li>lowering the threshold for treating stage 1 hypertension in patients < 80 years from 20% to 10%</li><li>angiotensin receptor blockers can be used instead of ACE-inhibitors where indicated</li><li>if a patient is already taking an ACE-inhibitor or angiotensin receptor blocker, then a calcium channel blocker OR a thiazide-like diuretic can be used. Previously only a calcium channel blocker was recommended</li></ul><br /><h5 class='notes-heading'>Blood pressure classification</h5><br />This becomes relevant later in some of the management decisions that NICE advocates.<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Stage</b></th><th><b>Criteria</b></th></tr></thead><tbody><tr><td><b>Stage 1 hypertension</b></td><td>Clinic BP >= <span class=\"concept\" data-cid=\"6674\">140/90 mmHg</span> and subsequent ABPM daytime average or HBPM average BP >= <span class=\"concept\" data-cid=\"6675\">135/85 mmHg</span></td></tr><tr><td><b>Stage 2 hypertension</b></td><td>Clinic BP >= <span class=\"concept\" data-cid=\"6676\">160/100 mmHg</span> and subsequent ABPM daytime average or HBPM average BP >= <span class=\"concept\" data-cid=\"6677\">150/95 mmHg</span></td></tr><tr><td><b>Severe hypertension</b></td><td><span class=\"concept\" data-cid=\"6673\">Clinic systolic BP >= 180 mmHg, or clinic diastolic BP >= 120 mmHg</span></td></tr></tbody></table></div><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd927b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd927.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd927b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Flow chart showing simplified schematic for diagnosis hypertension following NICE guidelines</div><br /><h5 class='notes-heading'>Managing hypertension</h5><br />Lifestyle advice should not be forgotten and is frequently tested in exams:<br /><ul><li><span class=\"concept\" data-cid=\"10294\">a low salt diet is recommended, aiming for less than 6g/day</span>, ideally 3g/day. The average adult in the UK consumes around 8-12g/day of salt. A recent BMJ paper* showed that lowering salt intake can have a significant effect on blood pressure. For example, reducing salt intake by 6g/day can lower systolic blood pressure by 10mmHg</li><li>caffeine intake should be reduced</li><li>the other general bits of advice remain: stop smoking, drink less alcohol, eat a balanced diet rich in fruit and vegetables, exercise more, lose weight</li></ul><br />ABPM/HBPM >= <span class=\"concept\" data-cid=\"6675\">135/85 mmHg</span> (i.e. stage 1 hypertension)<br /><ul><li>treat if < 80 years of age AND any of the following apply; target organ damage, established cardiovascular disease, renal disease, diabetes or a 10-year cardiovascular risk equivalent to 10% or greater</li><li>in 2019, NICE made a further recommendation, suggesting that we should <i>'consider antihypertensive drug treatment in addition to lifestyle advice for adults aged under 60 with stage 1 hypertension and an estimated 10-year risk below 10%. '</i>. This seems to be due to evidence that QRISK may underestimate the lifetime probability of developing cardiovascular disease</li></ul><br />ABPM/HBPM >= <span class=\"concept\" data-cid=\"6677\">150/95 mmHg</span> (i.e. stage 2 hypertension)<br /><ul><li>offer drug treatment regardless of age</li></ul><br />For patients < 40 years consider specialist referral to exclude secondary causes.<br /><br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd566b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd566.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd566b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Flow chart showing the management of hypertension as per current NICE guideliness</div><br /><br />Step 1 treatment<br /><ul><li><span class=\"concept\" data-cid=\"6670\">patients < 55-years-old</span> or a background of <span class=\"concept\" data-cid=\"9851\">type 2 diabetes mellitus</span>: <b>A</b>CE inhibitor or a <b>A</b>ngiotensin receptor blocker (<b>A</b>CE-i or <b>A</b>RB): <b>(A)</b><ul><li><span class=\"concept\" data-cid=\"922\">angiotensin receptor blockers should be used where ACE inhibitors are not tolerated (e.g. due to a cough)</span></li></ul></li><li><span class=\"concept\" data-cid=\"6671\">patients >= 55-years-old</span> or of <span class=\"concept\" data-cid=\"6672\">black African or African-Caribbean origin</span>: <b>C</b>alcium channel blocker <b>(C)</b><ul><li><span class=\"concept\" data-cid=\"916\">ACE inhibitors have reduced efficacy in patients of black African or African-Caribbean origin are therefore not used first-line</span></li></ul></li></ul><br />Step 2 treatment<br /><ul><li><span class=\"concept\" data-cid=\"6682\">if already taking an <b>A</b>CE-i or <b>A</b>RB add a <b>C</b>alcium channel blocker or a thiazide-like <b>D</b>iuretic</span></li><li><span class=\"concept\" data-cid=\"9850\">if already taking a <b>C</b>alcium channel blocker add an <b>A</b>CE-i or <b>A</b>RB or a thiazide-like <b>D</b>iuretic</span><ul><li><span class=\"concept\" data-cid=\"1386\">for patients of black African or African-Caribbean origin taking a calcium channel blocker for hypertension, if they require a second agent consider an angiotensin receptor blocker in preference to an ACE inhibitor</span></li></ul></li><li><b>(A + C) or (A + D)</b> or <b>(C + A) or (C + D)</b> </li></ul><br />Step 3 treatment<br /><ul><li>add a third drug to make, i.e.:<ul><li><span class=\"concept\" data-cid=\"6683\">if already taking an <b>(A + C)</b> then add a <b>D</b></span></li><li><span class=\"concept\" data-cid=\"9849\">if already <b>(A + D)</b> then add a <b>C</b></span></li></ul></li><li><b>(A + C + D)</b> </li></ul><br />Step 4 treatment<br /><ul><li>NICE define step 4 as resistant hypertension and suggest either adding a 4<sup>th</sup> drug (as below) or seeking specialist advice</li><li>first, check for:<ul><li>confirm elevated clinic BP with ABPM or HBPM</li><li>assess for postural hypotension.</li><li>discuss adherence</li></ul></li><li><span class=\"concept\" data-cid=\"6684\">if potassium < 4.5 mmol/l add low-dose spironolactone</span></li><li><span class=\"concept\" data-cid=\"6685\">if potassium > 4.5 mmol/l add an alpha- or beta-blocker</span></li></ul><br />Patients who fail to respond to step 4 measures should be referred to a specialist. NICE recommend:<br /><div class='bs-callout bs-callout-default'><i><i><br />If blood pressure remains uncontrolled with the optimal or maximum tolerated doses of four drugs, seek expert advice if it has not yet been obtained. <br /></i></i></div><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd973b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd973.png\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd974b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd974.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Blood pressure targets</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th></th><th><b>Clinic BP</b></th><th><b>ABPM / HBPM</b></th></tr></thead><tbody><tr><td><b>Age < 80 years</b></td><td><span class=\"concept\" data-cid=\"6678\">140/90 mmHg</span></td><td><span class=\"concept\" data-cid=\"6680\">135/85 mmHg</span></td></tr><tr><td><b>Age > 80 years</b></td><td><span class=\"concept\" data-cid=\"6679\">150/90 mmHg</span></td><td><span class=\"concept\" data-cid=\"6681\">145/85 mmHg</span></td></tr></tbody></table></div>",
        "notes_hash": "95248e6fb11c2374837320c9bd891a27",
        "knowledge_graph_node_id_link": 10012,
        "concept": "Poorly controlled hypertension, already taking an ACE inhibitor - add a calcium channel blocker or a thiazide-like diuretic",
        "concept_percentile": "47",
        "concept_colour": "rgb(255,239,0)",
        "number_attempts": "6480",
        "up_votes": "22",
        "down_votes": "9",
        "column_array": [
            0,
            "211",
            "436",
            "56",
            "5528",
            "249",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_978\" data-linkid=\"978\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_978\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">134</span><button type=\"button\" style=\"\" id=\"link_dislike_978\" data-linkid=\"978\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_978\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">121</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng136/chapter/Recommendations\">2019 Hypertension guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/LnGB7U1xIuw\" data-description=\"Hypertension Explained\" data-upvotes=\"14\" data-downvotes=\"8\" data-media=\"1380\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/LnGB7U1xIuw/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/LnGB7U1xIuw\" data-description=\"Hypertension Explained\" data-upvotes=\"14\" data-downvotes=\"8\" data-media=\"1380\">Hypertension Explained</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2429\" data-mediaid=\"2429\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2429\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"media_dislike_2429\" data-mediaid=\"2429\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2429\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "922": {
                "concept_text": "Angiotensin-receptor blockers should be used where ACE inhibitors are not tolerated",
                "concept_percentile": "32"
            },
            "1386": {
                "concept_text": "For patients of black African or African-Caribbean origin taking a calcium channel blocker for hypertension, if they require a second agent consider an angiotensin receptor blocker in preference to an ACE inhibitor",
                "concept_percentile": "73"
            },
            "6670": {
                "concept_text": "Newly diagnosed patient with hypertension (< 55 years) - add an ACE inhibitor or an angiotensin receptor blocker",
                "concept_percentile": "43"
            },
            "6671": {
                "concept_text": "Newly diagnosed patient with hypertension (> 55 years) - add a calcium channel blocker",
                "concept_percentile": "21"
            },
            "6672": {
                "concept_text": "Newly diagnosed patient of black African or African-Caribbean origin with hypertension - add a calcium channel blocker",
                "concept_percentile": "37"
            },
            "6673": {
                "concept_text": "Criteria for considering immediate treatment based on a clinic reading - 180/120 mmHg",
                "concept_percentile": "16"
            },
            "6674": {
                "concept_text": "Definition of stage 1 hypertension (Clinic reading) - 140/90 mmHg",
                "concept_percentile": "46"
            },
            "6675": {
                "concept_text": "Definition of stage 1 hypertension (ABPM/HBPM) - 135/85 mmHg",
                "concept_percentile": "19"
            },
            "6676": {
                "concept_text": "Definition of stage 2 hypertension (Clinic reading) - 160/100 mmHg",
                "concept_percentile": "34"
            },
            "6677": {
                "concept_text": "Definition of stage 2 hypertension (ABPM/HBPM) - 150/95 mmHg",
                "concept_percentile": "21"
            },
            "6678": {
                "concept_text": "Blood pressure target (< 80 years, clinic reading) - 140/90 mmHg",
                "concept_percentile": "26"
            },
            "6679": {
                "concept_text": "Blood pressure target (> 80 years, clinic reading) - 150/90 mmHg",
                "concept_percentile": "24"
            },
            "6680": {
                "concept_text": "Blood pressure target (< 80 years, ABPM/HBPM) - 135/85 mmHg",
                "concept_percentile": "23"
            },
            "6681": {
                "concept_text": "Blood pressure target (> 80 years, ABPM/HBPM) - 145/85 mmHg",
                "concept_percentile": "26"
            },
            "6682": {
                "concept_text": "Poorly controlled hypertension, already taking an ACE inhibitor - add a calcium channel blocker or a thiazide-like diuretic",
                "concept_percentile": "47"
            },
            "6683": {
                "concept_text": "Poorly controlled hypertension, already taking an ACE inhibitor and a calcium channel blocker - add a thiazide-like diuretic",
                "concept_percentile": "52"
            },
            "6684": {
                "concept_text": "Poorly controlled hypertension, already taking an ACE inhibitor, calcium channel blocker and a thiazide diuretic. K+ < 4.5mmol/l - add spironolactone",
                "concept_percentile": "56"
            },
            "6685": {
                "concept_text": "Poorly controlled hypertension, already taking an ACE inhibitor, calcium channel blocker and a standard-dose thiazide diuretic. K+ > 4.5mmol/l - add an alpha- or beta-blocker",
                "concept_percentile": "60"
            },
            "9849": {
                "concept_text": "Poorly controlled hypertension, already taking an ACE inhibitor and a thiazide diuretic - add a calcium channel blocker",
                "concept_percentile": "24"
            },
            "9850": {
                "concept_text": "Poorly controlled hypertension, already taking a calcium channel blocker - add an ACE inhibitor or an angiotensin receptor blocker or a thiazide-like diuretic",
                "concept_percentile": "46"
            },
            "9851": {
                "concept_text": "Newly diagnosed patient with hypertension who has a background of type 2 diabetes mellitus - add an ACE inhibitor or an angiotensin receptor blocker regardless of age",
                "concept_percentile": "72"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2134",
        "new_question_id": "4371",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1735",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Treat immediately with oral benzylpenicillin only",
            "Treat immediately with oral erythromycin & intrapartum intravenous benzylpenicillin",
            "No treatment required now, no intrapartum antibiotics",
            "Intrapartum intravenous benzylpenicillin only",
            "Intrapartum oral benzylpenicillin only",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 19-year-old woman who is 9 weeks into her first pregnancy is seen in the early pregnancy assessment unit with vaginal bleeding.  Her ultrasound scan confirms a viable intrauterine pregnancy.  However, the high vaginal swab has isolated group B streptococcus (GBS).  How should she be managed?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "GBS is a vaginal commensal isolated in many women.  It is known to be the most frequent cause of severe early-onset infection in the newborn and can cause significant morbidity and mortality.<br /><br />If it is isolated during the antenatal period, it does not require treatment immediately, as it will not reduce the likelihood of colonisation at delivery.<br /><br />However, intrapartum intravenous benzylpenicillin is required to reduce neonatal transmission.  An alternative would be clindamycin.  This applies to GBS isolated in vaginal swabs and urine.  (GBS urinary tract infection in pregnancy requires appropriate antibiotics at the time also).<br /><br />There is no screening programme in the UK for GBS, vaginal swabs should be taken only when clinically indicted.  Women who have had a previous baby infected with GBS are also offered intrapartum intravenous benzylpenicillin in future pregnancies.<br /><br />(Source - RCOG guidelines, GBS in pregnancy).",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 19-year-old woman who is 9 weeks into her first pregnancy is seen in the early pregnancy assessment unit with vaginal bleeding.  Her ultrasound scan confirms a viable intrauterine pregnancy.  However, the high vaginal swab has isolated group B streptococcus (GBS).  How should she be managed?",
        "correct_answer": "4",
        "question_notes": "GBS is a vaginal commensal isolated in many women.  It is known to be the most frequent cause of severe early-onset infection in the newborn and can cause significant morbidity and mortality.<br /><br />If it is isolated during the antenatal period, it does not require treatment immediately, as it will not reduce the likelihood of colonisation at delivery.<br /><br />However, intrapartum intravenous benzylpenicillin is required to reduce neonatal transmission.  An alternative would be clindamycin.  This applies to GBS isolated in vaginal swabs and urine.  (GBS urinary tract infection in pregnancy requires appropriate antibiotics at the time also).<br /><br />There is no screening programme in the UK for GBS, vaginal swabs should be taken only when clinically indicted.  Women who have had a previous baby infected with GBS are also offered intrapartum intravenous benzylpenicillin in future pregnancies.<br /><br />(Source - RCOG guidelines, GBS in pregnancy).",
        "answer_order": "4",
        "answer": "4",
        "title": "Group B <i>Streptococcus</i>",
        "body": "Group B <i>Streptococcus</i> (GBS) is the <span class=\"concept\" data-cid=\"3860\">most common cause of early-onset severe infection in the neonatal period</span>. It is thought around 20-40% of mothers have GBS present in their bowel flora and may therefore be thought of as 'carriers' of GBS. Infants may be exposed to maternal GBS during labour and subsequently develop potentially serious infections.<br /><br />Risk factors for Group B <i>Streptococcus</i> (GBS) infection:<br /><ul><li>prematurity</li><li>prolonged rupture of the membranes</li><li>previous sibling GBS infection</li><li>maternal pyrexia e.g. secondary to chorioamnionitis</li></ul><br /><h5 class='notes-heading'>Management</h5><br />The Royal College of Obstetricians and Gynaecologists (RCOG) published guidelines on GBS in 2017.<br /><br />The main points are as follows:<br /><ul><li>universal screening for GBS should not be offered to all women</li><li>the guidelines also state a maternal request is not an indication for screening</li><li><span class=\"concept\" data-cid=\"9776\">women who've had GBS detected in a previous pregnancy</span> should be informed that their risk of maternal GBS carriage in this pregnancy is 50%. They should be <span class=\"concept\" data-cid=\"9776\">offered intrapartum antibiotic prophylaxis (IAP) OR testing in late pregnancy and then antibiotics if still positive</span></li><li>if women are to have swabs for GBS this should be offered at 35-37 weeks or 3-5 weeks prior to the anticipated delivery date</li><li><span class=\"concept\" data-cid=\"998\">IAP should be offered to women with a previous baby with early- or late-onset GBS disease</span></li><li>IAP should be offered to women in preterm labour regardless of their GBS status</li><li><span class=\"concept\" data-cid=\"3571\">women with a pyrexia during labour (>38\u00baC) should also be given IAP</span></li><li><span class=\"concept\" data-cid=\"9147\">benzylpenicillin</span> is the antibiotic of choice for GBS prophylaxis</li></ul><br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd135b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd135.jpg'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd135b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Group B streptococcus bacteria. Credit: NIAID</div>",
        "notes_hash": "5c118d9bfd6c37814a8539ee6df8c4e9",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6245",
        "up_votes": "40",
        "down_votes": "35",
        "column_array": [
            0,
            "841",
            "1672",
            "410",
            "3062",
            "260",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1148\" data-linkid=\"1148\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1148\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"link_dislike_1148\" data-linkid=\"1148\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1148\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg149/chapter/1-Guidance\">2012 Neonatal infection (early onset): antibiotics for prevention and treatment</a></td></tr></table><br><br><table style='width:100%'><tr><td>RCOG</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_109\" data-linkid=\"109\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_109\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_109\" data-linkid=\"109\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_109\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.14821\">2017 Group B Streptococcus guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/pR6jDZhszmk\" data-description=\"Streptococcus agalactiae\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"863\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/pR6jDZhszmk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/pR6jDZhszmk\" data-description=\"Streptococcus agalactiae\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"863\">Streptococcus agalactiae</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1510\" data-mediaid=\"1510\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1510\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_1510\" data-mediaid=\"1510\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1510\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 6,
        "concepts_for_notes": {
            "998": {
                "concept_text": "Maternal intravenous antibiotic prophylaxis should be offered to women with a previous baby with early- or late-onset GBS disease",
                "concept_percentile": "97"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_41",
        "new_question_id": "1781",
        "question_type": "1",
        "category": "8",
        "concept_id_link": "0",
        "notes_id_link": "1_1214",
        "theme": "Tumour markers",
        "instruction": "For each one of the following select the most likely diagnosis from the options above:",
        "options": [
            "",
            "Breast cancer",
            "Prostate cancer",
            "Gastric cancer",
            "Ovarian cancer",
            "Colorectal cancer",
            "Pancreatic cancer",
            "Seminoma testicular cancer",
            "Non-seminomatous testicular cancer",
            "Liver cancer",
            ""
        ],
        "num_of_options": 9,
        "questions": [
            "Raised beta-human chorionic gonadotropin with a raised alpha-feto protein level in a male patient",
            "Tatkpits RP 19-9",
            "Gpxhts paewp-utid egditxc atkta xc p 54-ntpg-das ldbpc"
        ],
        "answers": [
            "8",
            "6",
            "9"
        ],
        "notes": [
            "A raised alpha-feto protein level excludes a seminoma",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Raised beta-human chorionic gonadotropin with a raised alpha-feto protein level in a male patient",
        "correct_answer": "8",
        "question_notes": "A raised alpha-feto protein level excludes a seminoma",
        "answer_order": "8",
        "answer": "8",
        "title": "Tumour markers",
        "body": "Tumour markers may be divided into:<br /><ul><li>monoclonal antibodies against carbohydrate or glycoprotein tumour antigens</li><li>tumour antigens</li><li>enzymes (alkaline phosphatase, neurone specific enolase)</li><li>hormones (e.g. calcitonin, ADH)</li></ul><br />It should be noted that tumour markers usually have a low specificity<br /><br /><h5 class='notes-heading'>Monoclonal antibodies</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Tumour marker</b></th><th><b>Association</b></th></tr></thead><tbody><tr><td>CA 125</td><td><span class=\"concept\" data-cid=\"7679\">Ovarian cancer</span></td></tr><tr><td>CA 19-9</td><td><span class=\"concept\" data-cid=\"7680\">Pancreatic cancer</span></td></tr><tr><td>CA 15-3</td><td><span class=\"concept\" data-cid=\"4848\">Breast cancer</span></td></tr></tbody></table></div><br /><h5 class='notes-heading'>Tumour antigens</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>Tumour marker</b></th><th><b>Association</b></th></tr></thead><tbody><tr><td>Prostate specific antigen (PSA)</td><td>Prostatic carcinoma</td></tr><tr><td>Alpha-feto protein (AFP)</td><td><span class=\"concept\" data-cid=\"7681\">Hepatocellular carcinoma</span>, <span class=\"concept\" data-cid=\"7682\">teratoma</span></td></tr><tr><td>Carcinoembryonic antigen (CEA)</td><td><span class=\"concept\" data-cid=\"1487\">Colorectal cancer</span></td></tr><tr><td>S-100</td><td><span class=\"concept\" data-cid=\"7683\">Melanoma</span>, <span class=\"concept\" data-cid=\"7684\">schwannoma</span>s</td></tr><tr><td>Bombesin</td><td><span class=\"concept\" data-cid=\"4847\">Small cell lung carcinoma</span>, gastric cancer, <span class=\"concept\" data-cid=\"7685\">neuroblastoma</span></td></tr></tbody></table></div>",
        "notes_hash": "d890e7160baff9038e40eaa6766d412e",
        "knowledge_graph_node_id_link": 10569,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4023",
        "up_votes": "5",
        "down_votes": "7",
        "column_array": [
            0,
            "1059",
            "3404",
            "2859",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>National Cancer Institute</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_96\" data-linkid=\"96\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_96\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">35</span><button type=\"button\" style=\"\" id=\"link_dislike_96\" data-linkid=\"96\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_96\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet\">Tumour markers</a></td></tr></table>",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": {
            "1487": {
                "concept_text": "Carcinoembryonic Antigen (CEA) is a tumour marker in colorectal cancer and has a role in monitoring disease activity",
                "concept_percentile": "38"
            },
            "4848": {
                "concept_text": "CA 15-3 is a tumour marker in breast cancers",
                "concept_percentile": "27"
            },
            "7679": {
                "concept_text": "Ovarian cancer - CA 125",
                "concept_percentile": "17"
            },
            "7680": {
                "concept_text": "Pancreatic cancer - CA 19-9",
                "concept_percentile": "33"
            },
            "7681": {
                "concept_text": "Hepatocellular carcinoma - alpha-feto protein",
                "concept_percentile": "50"
            },
            "7682": {
                "concept_text": "Teratoma - alpha-feto protein",
                "concept_percentile": "35"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2095",
        "new_question_id": "61181",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "10829",
        "notes_id_link": "1_1182",
        "theme": "Rate control in atrial fibrillation with asthma",
        "instruction": "",
        "options": [
            "",
            "Amiodarone",
            "Bisoprolol",
            "Diltiazem",
            "Digoxin",
            "Flecainide",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 64-year-old man presents with a 3-day history of palpitations and mild breathlessness. He has a history of well-controlled asthma. On examination, his pulse is 130 bpm and irregularly irregular. His blood pressure is 138/84 mmHg and his chest is clear.<br /><br />Select the single most appropriate initial medication from the options below.",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "This patient has new-onset atrial fibrillation with a rapid ventricular response and is haemodynamically stable. The onset is greater than 48 hours, so the initial management strategy according to NICE guidelines is rate control. The choice of agent depends on the patient's comorbidities. <br /><br /><b>Diltiazem</b> is the correct answer. It is a rate-limiting calcium channel blocker. Along with beta-blockers, rate-limiting calcium channel blockers are recommended as first-line agents for rate control in atrial fibrillation. In this patient, who has a history of asthma, beta-blockers are contraindicated due to the risk of inducing bronchospasm. Therefore, a rate-limiting calcium channel blocker such as diltiazem or verapamil is the most appropriate first-line choice. The patient is haemodynamically stable with no signs of heart failure, making this a safe and effective option to control the ventricular rate.<br /><br /><b>Bisoprolol</b> is a beta-blocker and a first-line agent for rate control in many patients with atrial fibrillation. However, beta-blockers can cause bronchoconstriction by blocking beta-2 receptors in the lungs and are therefore relatively contraindicated in patients with asthma. While cardioselective beta-blockers like bisoprolol have less effect on beta-2 receptors, caution is still advised, and they are generally avoided as a first-line choice in this context, especially when a safe alternative like a calcium channel blocker is available. Given the potential for significant respiratory compromise, it is not the most appropriate initial choice.<br /><br /><b>Amiodarone</b> can be used for both rate and rhythm control. However, due to its extensive and potentially serious side-effect profile (including thyroid, liver, and pulmonary toxicity), it is not a first-line agent for rate control in a stable patient. It is typically reserved for patients who are haemodynamically unstable, have co-existing heart failure, or are refractory to other first-line agents. This patient is stable and has not yet trialled appropriate first-line therapy.<br /><br /><b>Digoxin</b> is a cardiac glycoside that can be used for rate control. However, NICE guidelines no longer recommend it as a first-line monotherapy agent, particularly in non-sedentary patients, as it is less effective at controlling the heart rate during exercise. It is typically considered as an add-on therapy if first-line agents are insufficient, or as monotherapy in patients who are sedentary or have co-existing heart failure where beta-blockers are contraindicated. This patient has no signs of heart failure, so a calcium channel blocker is preferred.<br /><br /><b>Flecainide</b> is a Class Ic antiarrhythmic drug used for rhythm control (i.e., to restore and maintain sinus rhythm), not rate control. It is used either as a 'pill-in-the-pocket' strategy for paroxysmal AF or for pharmacological cardioversion. It is contraindicated in patients with structural or ischaemic heart disease. The immediate priority in this stable patient is to control the ventricular rate, not to attempt cardioversion.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 64-year-old man presents with a 3-day history of palpitations and mild breathlessness. He has a history of well-controlled asthma. On examination, his pulse is 130 bpm and irregularly irregular. His blood pressure is 138/84 mmHg and his chest is clear.<br /><br />Select the single most appropriate initial medication from the options below.",
        "correct_answer": "3",
        "question_notes": "This patient has new-onset atrial fibrillation with a rapid ventricular response and is haemodynamically stable. The onset is greater than 48 hours, so the initial management strategy according to NICE guidelines is rate control. The choice of agent depends on the patient's comorbidities. <br /><br /><b>Diltiazem</b> is the correct answer. It is a rate-limiting calcium channel blocker. Along with beta-blockers, rate-limiting calcium channel blockers are recommended as first-line agents for rate control in atrial fibrillation. In this patient, who has a history of asthma, beta-blockers are contraindicated due to the risk of inducing bronchospasm. Therefore, a rate-limiting calcium channel blocker such as diltiazem or verapamil is the most appropriate first-line choice. The patient is haemodynamically stable with no signs of heart failure, making this a safe and effective option to control the ventricular rate.<br /><br /><b>Bisoprolol</b> is a beta-blocker and a first-line agent for rate control in many patients with atrial fibrillation. However, beta-blockers can cause bronchoconstriction by blocking beta-2 receptors in the lungs and are therefore relatively contraindicated in patients with asthma. While cardioselective beta-blockers like bisoprolol have less effect on beta-2 receptors, caution is still advised, and they are generally avoided as a first-line choice in this context, especially when a safe alternative like a calcium channel blocker is available. Given the potential for significant respiratory compromise, it is not the most appropriate initial choice.<br /><br /><b>Amiodarone</b> can be used for both rate and rhythm control. However, due to its extensive and potentially serious side-effect profile (including thyroid, liver, and pulmonary toxicity), it is not a first-line agent for rate control in a stable patient. It is typically reserved for patients who are haemodynamically unstable, have co-existing heart failure, or are refractory to other first-line agents. This patient is stable and has not yet trialled appropriate first-line therapy.<br /><br /><b>Digoxin</b> is a cardiac glycoside that can be used for rate control. However, NICE guidelines no longer recommend it as a first-line monotherapy agent, particularly in non-sedentary patients, as it is less effective at controlling the heart rate during exercise. It is typically considered as an add-on therapy if first-line agents are insufficient, or as monotherapy in patients who are sedentary or have co-existing heart failure where beta-blockers are contraindicated. This patient has no signs of heart failure, so a calcium channel blocker is preferred.<br /><br /><b>Flecainide</b> is a Class Ic antiarrhythmic drug used for rhythm control (i.e., to restore and maintain sinus rhythm), not rate control. It is used either as a 'pill-in-the-pocket' strategy for paroxysmal AF or for pharmacological cardioversion. It is contraindicated in patients with structural or ischaemic heart disease. The immediate priority in this stable patient is to control the ventricular rate, not to attempt cardioversion.",
        "answer_order": "3",
        "answer": "3",
        "title": "Atrial fibrillation: rate control and maintenance of sinus rhythm",
        "body": "NICE updated its guidelines on the management of atrial fibrillation (AF) in 2021. The following is also based on the joint American Heart Association (AHA), American College of Cardiology (ACC) and European Society of Cardiology (ESC) 2012 guidelines<br /><br /><h5 class='notes-heading'>Patients presenting acutely with AF</h5><br />If a patient has signs of haemodynamic instability (e.g. hypotension, heart failure) they should be <span class=\"concept\" data-cid=\"11783\">electrically cardioverted</span>, as per the peri-arrest tachycardia guidelines.<br /><br />For haemodynamically stable patients, the management depends on how acute the AF is:<br /><ul><li>< 48 hours:  rate or rhythm control</li><li><span class=\"concept\" data-cid=\"11784\">\u2265 48 hours or uncertain (e.g. patient not sure when symptoms started): rate control</span><ul><li>if considered for long-term rhythm control, delay cardioversion until they have been maintained on therapeutic anticoagulation for a <span class=\"concept\" data-cid=\"11785\">minimum of 3 weeks</span></li></ul></li><li>anticoagulation<ul><li><span class=\"concept\" data-cid=\"12390\">all patients with new-onset AF require anticoagulation, regardless of onset</span></li><li>long-term anticoagulation is based on the CHA<sub>2</sub>DS<sub>2</sub>-VASc score</li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg088b.png\" data-fancybox=\"gallery\" data-caption=\"Atrial fibrillation - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg088.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Rate control</h5><br />Rate control should be offered as the first-line treatment strategy for atrial fibrillation except in people:<br /><ul><li>whose atrial fibrillation has a reversible cause</li><li>who have heart failure thought to be primarily caused by atrial fibrillation</li><li>with new-onset atrial fibrillation (< 48 hours)</li><li>with atrial flutter whose condition is considered suitable for an ablation strategy to restore sinus rhythm</li><li>for whom a rhythm-control strategy would be more suitable based on clinical judgement</li></ul><br /><h6 class='notes-subheading'>Medications</h6><br />Agents used to control rate in patients with atrial fibrillation<br /><ul><li><span class=\"concept\" data-cid=\"200\">beta-blockers</span><ul><li><span class=\"concept\" data-cid=\"10829\">a common contraindication for beta-blockers is asthma</span></li></ul></li><li>calcium channel blockers</li><li><span class=\"concept\" data-cid=\"3135\">digoxin</span><ul><li>not considered first-line anymore as they are less effective at controlling the heart rate during exercise</li><li>should only be considered if the person does no or very little physical exercise or other rate-limiting drug options are ruled out because of comorbidities </li><li>may have a role if there is coexistent heart failure</li></ul></li></ul><br /><h5 class='notes-heading'>Rhythm control</h5><br />Agents used to maintain sinus rhythm in patients with a history of atrial fibrillation<br /><ul><li>beta-blockers</li><li>dronedarone: second-line in patients following cardioversion</li><li>amiodarone: particularly if coexisting heart failure </li></ul><br /><br /><h5 class='notes-heading'>Catheter ablation</h5><br />NICE recommends the use of catheter ablation for those with AF who have not responded to or wish to avoid, antiarrhythmic medication.<br /><br />Technical aspects<br /><ul><li>the aim is to ablate the faulty electrical pathways that are resulting in atrial fibrillation. This is typically due to <span class=\"concept\" data-cid=\"10663\">aberrant electrical activity between the pulmonary veins and left atrium</span></li><li>the procedure is performed percutaneously, typically via the groin</li><li>both radiofrequency (uses heat generated from medium frequency alternating current) and cryotherapy can be used to ablate the tissue</li></ul><br />Anticoagulation <br /><ul><li>should be used 4 weeks before and during the procedure</li><li>it should be remember that catheter ablation controls the rhythm but does not reduce the stroke risk, even if patients remain in sinus rhythm. Therefore, <span class=\"concept\" data-cid=\"10662\">patients still require anticoagulation as per their CHA<sub>2</sub>DS<sub>2</sub>-VASc score</span><ul><li>if score = 0: 2 months anticoagulation recommended</li><li>if score > 1: longterm anticoagulation recommended</li></ul></li></ul><br />Outcome<br /><ul><li>notable complications include<ul><li>cardiac tamponade</li><li>stroke</li><li>pulmonary vein stenosis</li></ul></li><li>success rate<ul><li>around 50% of patients experience an early recurrence (within 3 months) of AF that often resolves spontaneously</li><li>longer term, after 3 years, around 55% of patients who've had a single procedure remain in sinus rhythm. Of patients who've undergone multiple procedures around 80% are in sinus rhythm</li></ul></li></ul>",
        "notes_hash": "e9661ae706ac2fe13caef3b9d80ba0f4",
        "knowledge_graph_node_id_link": 1162,
        "concept": "Beta-blockers are contraindicated in patients with asthma when managing atrial fibrillation",
        "concept_percentile": "100",
        "concept_colour": "rgb(0,255,0)",
        "number_attempts": "115",
        "up_votes": "0",
        "down_votes": "0",
        "column_array": [
            0,
            "6",
            "28",
            "49",
            "26",
            "6",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2046\" data-linkid=\"2046\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2046\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">32</span><button type=\"button\" style=\"\" id=\"link_dislike_2046\" data-linkid=\"2046\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2046\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng196/chapter/Recommendations\">2021 Atrial fibrillation guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>European Society of Cardiology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_32\" data-linkid=\"32\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_32\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_32\" data-linkid=\"32\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_32\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://academic.oup.com/eurheartj/article/42/5/373/5899003\">2020 Atrial fibrillation guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/J33lfh6w3gI\" data-description=\"Understanding Atrial Fibrillation\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1688\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/J33lfh6w3gI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/J33lfh6w3gI\" data-description=\"Understanding Atrial Fibrillation\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1688\">Understanding Atrial Fibrillation</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2869\" data-mediaid=\"2869\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2869\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2869\" data-mediaid=\"2869\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2869\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wxJuP-i9Jx0\" data-description=\"Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications\" data-upvotes=\"6\" data-downvotes=\"4\" data-media=\"1107\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/wxJuP-i9Jx0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wxJuP-i9Jx0\" data-description=\"Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications\" data-upvotes=\"6\" data-downvotes=\"4\" data-media=\"1107\">Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1917\" data-mediaid=\"1917\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1917\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_1917\" data-mediaid=\"1917\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1917\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "200": {
                "concept_text": "Atrial fibrillation: rate control - beta blockers preferable to digoxin",
                "concept_percentile": "54"
            },
            "10662": {
                "concept_text": "Patients who've had a catheter ablation for atrial fibrillation still require long-term anticoagulation as per their CHA<sub>2</sub>DS<sub>2</sub>-VASc score ",
                "concept_percentile": "93"
            },
            "10829": {
                "concept_text": "Beta-blockers are contraindicated in patients with asthma when managing atrial fibrillation",
                "concept_percentile": "100"
            },
            "11783": {
                "concept_text": "Acute presentation of atrial fibrillation: if signs of haemodynamic instability (e.g. hypotension, heart failure) --> electrical cardioversion, as per the peri-arrest tachycardia guidelines",
                "concept_percentile": "60"
            },
            "11784": {
                "concept_text": "Acute onset of atrial fibrillation: if \u2265 48 hours or uncertain (e.g. patient not sure when symptoms started) --> rate control",
                "concept_percentile": "89"
            },
            "11785": {
                "concept_text": "Acute onset of atrial fibrillation: if \u2265 48 hours - rate control initially, then if considered for long-term rhythm control, delay cardioversion until they have been maintained on therapeutic anticoagulation for a minimum of 3 weeks",
                "concept_percentile": "87"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1522",
        "new_question_id": "9617",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_629",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Erythema multiforme",
            "Erythema chronica migrans",
            "Erythema nodosum",
            "Urticaria",
            "Dermatitis artefacta",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 2-year-old girl develops a rash on her legs. The next day she is brought to surgery, by which time the rash has spread to the rest of her body.<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "The classic 'target' lesions of erythema multiforme can be seen clearly on this image.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 2-year-old girl develops a rash on her legs. The next day she is brought to surgery, by which time the rash has spread to the rest of her body.<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><br />What is the most likely diagnosis?",
        "correct_answer": "1",
        "question_notes": "The classic 'target' lesions of erythema multiforme can be seen clearly on this image.",
        "answer_order": "1",
        "answer": "1",
        "title": "Erythema multiforme",
        "body": "Erythema multiforme is a hypersensitivity reaction that is most commonly triggered by infections. It may be divided into minor and major forms.<br /><br />Previously it was thought that Stevens-Johnson syndrome (SJS) was a severe form of erythema multiforme. They are now however considered as separate entities.<br /><br />Features<br /><ul><li>target lesions</li><li>initially seen on the back of the hands / feet before spreading to the torso</li><li>upper limbs are more commonly affected than the lower limbs</li><li>pruritus is occasionally seen and is usually mild</li></ul><br />Causes<br /><ul><li>viruses: herpes simplex virus (the most common cause), Orf*</li><li>idiopathic</li><li>bacteria: <i>Mycoplasma</i>, <i>Streptococcus</i></li><li>drugs: penicillin, sulphonamides, carbamazepine, allopurinol, NSAIDs, oral contraceptive pill, nevirapine</li><li>connective tissue disease e.g. Systemic lupus erythematosus</li><li>sarcoidosis</li><li>malignancy</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd001b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd001.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd002b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd002.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd003.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd941b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd941.jpg\" alt=\"\" /></a></div></div><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd942b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme on the right side of the neck. In this case, developed after the onset of herpes labailis\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd942.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd943b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme - giant target lesions on her forearms\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd943.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd004b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd004.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd001b.jpg\" data-fancybox=\"gallery\" data-caption=\"Erythema multiforme\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd001.jpg\" alt=\"\" /></a></div></div><div class=\"row\"></div></div><br /><h5 class='notes-heading'>Erythema multiforme major</h5><br />The more severe form, erythema multiforme major is associated with mucosal involvement.<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd463b.jpg\" data-fancybox=\"gallery\" data-caption=\"This image shows the ventral and lateral surfaces of the tongue with multiple irregular, erythematous patches and areas of epithelial sloughing and superficial ulceration, consistent with mucosal erosions. The lesions have a geographic and well-demarcated appearance, and are surrounded by erythematous mucosa, indicating active inflammation. These findings are characteristic of erythema multiforme major, which typically involves painful mucosal erosions (oral, ocular, or genital) in conjunction with targetoid skin lesions. Erythema multiforme major is often precipitated by HSV infection or medications and requires prompt recognition.\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd463.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd115.jpg\" data-fancybox=\"gallery\" data-caption=\"Example of mucosal involvement in erythema multiforme major\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd115.jpg\" alt=\"\" /></a></div></div></div><br />*Orf is a skin disease of sheep and goats caused by a parapox virus",
        "notes_hash": "6894b0b812d0342a75faf627e8ea52aa",
        "knowledge_graph_node_id_link": 10471,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5094",
        "up_votes": "31",
        "down_votes": "27",
        "column_array": [
            0,
            "3889",
            "225",
            "209",
            "730",
            "41",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_56\" data-linkid=\"56\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_56\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">19</span><button type=\"button\" style=\"\" id=\"link_dislike_56\" data-linkid=\"56\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_56\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">12</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.dermnetnz.org/topics/erythema-multiforme/\">Erythema multiforme</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1NeeMpKzHFo\" data-description=\"Erythema multiforme\" data-upvotes=\"13\" data-downvotes=\"0\" data-media=\"1448\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/1NeeMpKzHFo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1NeeMpKzHFo\" data-description=\"Erythema multiforme\" data-upvotes=\"13\" data-downvotes=\"0\" data-media=\"1448\">Erythema multiforme</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2560\" data-mediaid=\"2560\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2560\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"media_dislike_2560\" data-mediaid=\"2560\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2560\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 7,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2078",
        "new_question_id": "61154",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "10590",
        "notes_id_link": "1_1831",
        "theme": "Exertional syncope with T wave inversion in V1-V3",
        "instruction": "",
        "options": [
            "",
            "Arrhythmogenic right ventricular cardiomyopathy",
            "Brugada syndrome",
            "Hypertrophic cardiomyopathy",
            "Athletic heart syndrome",
            "Pulmonary embolism",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 22-year-old man presents to the Emergency Department after a syncopal episode while playing football. His cardiovascular examination is unremarkable. An ECG shows sinus rhythm with T wave inversion in leads V1 to V3.<br /><br />Select the single most likely diagnosis from the options below.",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Arrhythmogenic right ventricular cardiomyopathy</b> is the most likely diagnosis. ARVC is an inherited cardiomyopathy characterised by the progressive replacement of the right ventricular myocardium with fibrofatty tissue. This predisposes individuals to life-threatening ventricular arrhythmias and sudden cardiac death, particularly during exertion. The presentation of syncope during sport in a young male is classic. The key diagnostic clue here is the ECG finding of T wave inversion in the right precordial leads (V1-V3). This is a major criterion in the 2010 Task Force Criteria for diagnosing ARVC. While other ECG features like an epsilon wave (a terminal notch in the QRS complex) are more specific, they are only present in around 50% of cases. The T wave inversion in V1-V3 in a person over 14 years of age, in the absence of complete right bundle branch block, is a significant red flag for ARVC and warrants further investigation with cardiac MRI and potentially genetic testing.<br /><br /><b>Brugada syndrome</b> is an important differential for sudden cardiac death in the young. It is a genetic sodium channelopathy that also causes characteristic ECG changes in the right precordial leads (V1-V3). However, the classic Brugada pattern (Type 1) is coved ST-segment elevation of at least 2mm, followed by a negative T-wave. The question describes isolated T-wave inversion without mentioning the characteristic ST elevation, making Brugada syndrome less likely than ARVC. Both conditions can present with syncope and affect similar ECG leads, making this a challenging but important distinction.<br /><br /><b>Hypertrophic cardiomyopathy</b> (HCM) is the most common cause of sudden cardiac death in young athletes and a key differential for exertional syncope. It is an inherited condition causing hypertrophy of the left ventricle. While ECG abnormalities are common in HCM, including T-wave inversion, these changes are typically seen in the lateral leads (I, aVL, V5, V6) reflecting the underlying left ventricular pathology. Isolated T-wave inversion in the right precordial leads (V1-V3) is not a typical feature of HCM, making it a less likely diagnosis in this specific scenario.<br /><br /><b>Athletic heart syndrome</b> refers to the physiological cardiac remodelling that occurs in response to intense physical training. This can result in various ECG changes, including sinus bradycardia, voltage criteria for ventricular hypertrophy, and sometimes T-wave inversion. However, T-wave inversion in V1-V3 in a white athlete is considered an abnormal finding that requires further investigation to exclude underlying pathology such as ARVC. Benign T-wave inversion related to athletic training is more commonly seen in leads V4-V6 in athletes of Afro-Caribbean descent. Therefore, attributing this ECG to a benign physiological change would be inappropriate.<br /><br /><b>Pulmonary embolism</b> can cause syncope and ECG changes due to acute right ventricular strain. These changes can include T-wave inversion in the right precordial leads (V1-V3) and the inferior leads. While a PE is a possible cause of syncope, it is less likely in this context. A PE large enough to cause syncope would typically be associated with other symptoms such as acute-onset dyspnoea, pleuritic chest pain, or haemoptysis. The presentation of an isolated syncopal episode during exercise in an otherwise well young man points more towards a primary arrhythmogenic cause.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 22-year-old man presents to the Emergency Department after a syncopal episode while playing football. His cardiovascular examination is unremarkable. An ECG shows sinus rhythm with T wave inversion in leads V1 to V3.<br /><br />Select the single most likely diagnosis from the options below.",
        "correct_answer": "1",
        "question_notes": "<b>Arrhythmogenic right ventricular cardiomyopathy</b> is the most likely diagnosis. ARVC is an inherited cardiomyopathy characterised by the progressive replacement of the right ventricular myocardium with fibrofatty tissue. This predisposes individuals to life-threatening ventricular arrhythmias and sudden cardiac death, particularly during exertion. The presentation of syncope during sport in a young male is classic. The key diagnostic clue here is the ECG finding of T wave inversion in the right precordial leads (V1-V3). This is a major criterion in the 2010 Task Force Criteria for diagnosing ARVC. While other ECG features like an epsilon wave (a terminal notch in the QRS complex) are more specific, they are only present in around 50% of cases. The T wave inversion in V1-V3 in a person over 14 years of age, in the absence of complete right bundle branch block, is a significant red flag for ARVC and warrants further investigation with cardiac MRI and potentially genetic testing.<br /><br /><b>Brugada syndrome</b> is an important differential for sudden cardiac death in the young. It is a genetic sodium channelopathy that also causes characteristic ECG changes in the right precordial leads (V1-V3). However, the classic Brugada pattern (Type 1) is coved ST-segment elevation of at least 2mm, followed by a negative T-wave. The question describes isolated T-wave inversion without mentioning the characteristic ST elevation, making Brugada syndrome less likely than ARVC. Both conditions can present with syncope and affect similar ECG leads, making this a challenging but important distinction.<br /><br /><b>Hypertrophic cardiomyopathy</b> (HCM) is the most common cause of sudden cardiac death in young athletes and a key differential for exertional syncope. It is an inherited condition causing hypertrophy of the left ventricle. While ECG abnormalities are common in HCM, including T-wave inversion, these changes are typically seen in the lateral leads (I, aVL, V5, V6) reflecting the underlying left ventricular pathology. Isolated T-wave inversion in the right precordial leads (V1-V3) is not a typical feature of HCM, making it a less likely diagnosis in this specific scenario.<br /><br /><b>Athletic heart syndrome</b> refers to the physiological cardiac remodelling that occurs in response to intense physical training. This can result in various ECG changes, including sinus bradycardia, voltage criteria for ventricular hypertrophy, and sometimes T-wave inversion. However, T-wave inversion in V1-V3 in a white athlete is considered an abnormal finding that requires further investigation to exclude underlying pathology such as ARVC. Benign T-wave inversion related to athletic training is more commonly seen in leads V4-V6 in athletes of Afro-Caribbean descent. Therefore, attributing this ECG to a benign physiological change would be inappropriate.<br /><br /><b>Pulmonary embolism</b> can cause syncope and ECG changes due to acute right ventricular strain. These changes can include T-wave inversion in the right precordial leads (V1-V3) and the inferior leads. While a PE is a possible cause of syncope, it is less likely in this context. A PE large enough to cause syncope would typically be associated with other symptoms such as acute-onset dyspnoea, pleuritic chest pain, or haemoptysis. The presentation of an isolated syncopal episode during exercise in an otherwise well young man points more towards a primary arrhythmogenic cause.",
        "answer_order": "1",
        "answer": "1",
        "title": "Arrhythmogenic right ventricular cardiomyopathy",
        "body": "Arrhythmogenic right ventricular cardiomyopathy (ARVC, also known as arrhythmogenic right ventricular dysplasia or ARVD) is a form of inherited cardiovascular disease which may present with syncope or sudden cardiac death. It is generally regarded as the second most common cause of sudden cardiac death in the young after hypertrophic cardiomyopathy.<br /><br />Pathophysiology<br /><ul><li>inherited in an autosomal dominant pattern with variable expression</li><li>the <span class=\"concept\" data-cid=\"3897\">right ventricular myocardium is replaced by fatty and fibrofatty tissue</span></li><li>around 50% of patients have a mutation of one of the several genes which encode components of desmosome</li></ul><br />Presentation<br /><ul><li>palpitations</li><li>syncope</li><li>sudden cardiac death</li></ul><br />Investigation<br /><ul><li><span class=\"concept\" data-cid=\"10590\">ECG abnormalities in V1-3, typically T wave inversion</span>. An <span class=\"concept\" data-cid=\"2494\">epsilon wave</span> is found in about 50% of those with ARV - this is best described as a terminal notch in the QRS complex</li><li>echo changes are often subtle in the early stages but may show an enlarged, hypokinetic right ventricle with a thin free wall</li><li>magnetic resonance imaging is useful to show fibrofatty tissue</li></ul><br />Management<br /><ul><li>drugs: sotalol is the most widely used antiarrhythmic</li><li>catheter ablation to prevent ventricular tachycardia</li><li>implantable cardioverter-defibrillator</li></ul><br />Naxos disease<br /><ul><li>an autosomal recessive variant of ARVC</li><li>a triad of ARVC, palmoplantar keratosis, and woolly hair</li></ul>",
        "notes_hash": "10bd9e93f3a9a47359ba83efdcd772f2",
        "knowledge_graph_node_id_link": 11042,
        "concept": "Arrhythmogenic right ventricular cardiomyopathy - T wave inversion in V1-3",
        "concept_percentile": "87",
        "concept_colour": "rgb(66,255,0)",
        "number_attempts": "2828",
        "up_votes": "7",
        "down_votes": "10",
        "column_array": [
            0,
            "399",
            "449",
            "1571",
            "381",
            "28",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Life in the fast lane</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_504\" data-linkid=\"504\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_504\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_504\" data-linkid=\"504\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_504\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/\">Arrhythmogenic right ventricular cardiomyopathy ECG</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Lm1HAmCnr9A\" data-description=\"Advanced EKGs - Sudden Cardiac Death (Hypertrophic cardiomyopathy, ARVD, Brugada syndrome, and CPVT)\" data-upvotes=\"9\" data-downvotes=\"0\" data-media=\"370\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Lm1HAmCnr9A/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Lm1HAmCnr9A\" data-description=\"Advanced EKGs - Sudden Cardiac Death (Hypertrophic cardiomyopathy, ARVD, Brugada syndrome, and CPVT)\" data-upvotes=\"9\" data-downvotes=\"0\" data-media=\"370\">Advanced EKGs - Sudden Cardiac Death (Hypertrophic cardiomyopathy, ARVD, Brugada syndrome, and CPVT)</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_626\" data-mediaid=\"626\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_626\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_626\" data-mediaid=\"626\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_626\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/u5cXomAW-bA\" data-description=\"Arrhythmogenic right ventricular cardiomyopathy\" data-upvotes=\"0\" data-downvotes=\"4\" data-media=\"1141\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/u5cXomAW-bA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/u5cXomAW-bA\" data-description=\"Arrhythmogenic right ventricular cardiomyopathy\" data-upvotes=\"0\" data-downvotes=\"4\" data-media=\"1141\">Arrhythmogenic right ventricular cardiomyopathy</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1973\" data-mediaid=\"1973\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1973\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_1973\" data-mediaid=\"1973\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1973\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "10590": {
                "concept_text": "Arrhythmogenic right ventricular cardiomyopathy - T wave inversion in V1-3",
                "concept_percentile": "87"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1019",
        "new_question_id": "2726",
        "question_type": "0",
        "category": "7",
        "concept_id_link": "2894",
        "notes_id_link": "1_1428",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Rheumatic fever",
            "Dermatomyositis",
            "Lyme disease",
            "Still's disease",
            "Kawasaki disease",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 4-year-old boy is reviewed in the Paediatric Admissions Unit. He has had a fever for the past week. On examination he has red, sore lips and conjunctival injection. He also has swollen, red hands. Blood tests show:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>13.1 g/dl</td></tr><tr><td>WBC</td><td>12.7 *10<sup>9</sup>/l</td></tr><tr><td>Platelets</td><td>520 *10<sup>9</sup>/l</td></tr><tr><td>CRP</td><td>96 mg/L</td></tr></tbody></table></div><br />What is the likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Kawasaki disease</b>. Kawasaki disease is an acute febrile vasculitis of childhood that predominantly affects children under the age of 5. It presents with fever lasting for at least five days, along with other clinical features such as bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities (e.g., swelling or redness), rash, and cervical lymphadenopathy. The patient's age, fever duration, and presence of characteristic findings (red, sore lips; conjunctival injection; swollen, red hands) are consistent with this diagnosis. Additionally, elevated CRP and thrombocytosis are common laboratory findings in Kawasaki disease.<br /><br /><b>Rheumatic fever</b> is a less likely diagnosis because it usually presents with migratory polyarthritis affecting large joints, carditis (including valvular involvement), chorea, erythema marginatum (a non-itchy rash), and subcutaneous nodules. Although fever can be present in rheumatic fever, the clinical features described in the question do not support this diagnosis.<br /><br /><b>Dermatomyositis</b> typically manifests as a progressive proximal muscle weakness accompanied by a characteristic skin rash involving the face, neck and upper trunk. While dermatomyositis may present with fever and skin manifestations such as Gottron's papules or heliotrope rash around eyes or on knuckles/elbows/knees/ankles/toes respectively, it does not involve lip erythema or conjunctival injection commonly seen in Kawasaki disease.<br /><br /><b>Lyme disease</b> is caused by infection with the spirochete <i>Borrelia burgdorferi</i>, transmitted through the bite of infected Ixodes ticks. Early Lyme disease can present with a characteristic erythema migrans rash, fever, and malaise. However, the clinical features described in the question, such as lip erythema and conjunctival injection, are not typical of Lyme disease. Additionally, Lyme disease is less common in children aged 4 years.<br /><br /><b>Still's disease</b>, also known as systemic juvenile idiopathic arthritis (sJIA), is a rare form of chronic arthritis in children characterized by high spiking fevers, an evanescent salmon-pink rash, and arthritis. Although the patient has fever and rash, the absence of joint involvement makes Still's disease less likely than Kawasaki disease given the clinical presentation.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 4-year-old boy is reviewed in the Paediatric Admissions Unit. He has had a fever for the past week. On examination he has red, sore lips and conjunctival injection. He also has swollen, red hands. Blood tests show:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>13.1 g/dl</td></tr><tr><td>WBC</td><td>12.7 *10<sup>9</sup>/l</td></tr><tr><td>Platelets</td><td>520 *10<sup>9</sup>/l</td></tr><tr><td>CRP</td><td>96 mg/L</td></tr></tbody></table></div><br />What is the likely diagnosis?",
        "correct_answer": "5",
        "question_notes": "The correct answer is <b>Kawasaki disease</b>. Kawasaki disease is an acute febrile vasculitis of childhood that predominantly affects children under the age of 5. It presents with fever lasting for at least five days, along with other clinical features such as bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities (e.g., swelling or redness), rash, and cervical lymphadenopathy. The patient's age, fever duration, and presence of characteristic findings (red, sore lips; conjunctival injection; swollen, red hands) are consistent with this diagnosis. Additionally, elevated CRP and thrombocytosis are common laboratory findings in Kawasaki disease.<br /><br /><b>Rheumatic fever</b> is a less likely diagnosis because it usually presents with migratory polyarthritis affecting large joints, carditis (including valvular involvement), chorea, erythema marginatum (a non-itchy rash), and subcutaneous nodules. Although fever can be present in rheumatic fever, the clinical features described in the question do not support this diagnosis.<br /><br /><b>Dermatomyositis</b> typically manifests as a progressive proximal muscle weakness accompanied by a characteristic skin rash involving the face, neck and upper trunk. While dermatomyositis may present with fever and skin manifestations such as Gottron's papules or heliotrope rash around eyes or on knuckles/elbows/knees/ankles/toes respectively, it does not involve lip erythema or conjunctival injection commonly seen in Kawasaki disease.<br /><br /><b>Lyme disease</b> is caused by infection with the spirochete <i>Borrelia burgdorferi</i>, transmitted through the bite of infected Ixodes ticks. Early Lyme disease can present with a characteristic erythema migrans rash, fever, and malaise. However, the clinical features described in the question, such as lip erythema and conjunctival injection, are not typical of Lyme disease. Additionally, Lyme disease is less common in children aged 4 years.<br /><br /><b>Still's disease</b>, also known as systemic juvenile idiopathic arthritis (sJIA), is a rare form of chronic arthritis in children characterized by high spiking fevers, an evanescent salmon-pink rash, and arthritis. Although the patient has fever and rash, the absence of joint involvement makes Still's disease less likely than Kawasaki disease given the clinical presentation.",
        "answer_order": "5",
        "answer": "5",
        "title": "Kawasaki disease",
        "body": "Kawasaki disease is a type of vasculitis which is predominately seen in children. Whilst Kawasaki disease is uncommon it is important to recognise as it may cause potentially serious complications, including coronary artery aneurysms.<br /><br /><span class=\"concept\" data-cid=\"2894\">Features</span><br /><ul><li>high-grade fever which lasts for > 5 days. Fever is characteristically resistant to antipyretics</li><li>conjunctival injection</li><li>bright red, cracked lips</li><li>strawberry tongue</li><li>cervical lymphadenopathy</li><li>red palms of the hands and the soles of the feet which later peel</li></ul><br />Kawasaki disease is a clinical diagnosis as there is no specific diagnostic test.<br /><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"2893\">high-dose aspirin</span><ul><li>Kawasaki disease is one of the few indications for the use of aspirin in children. Due to the risk of Reye's syndrome aspirin is normally contraindicated in children</li></ul></li><li><span class=\"concept\" data-cid=\"7433\">intravenous immunoglobulin</span></li><li>echocardiogram (rather than angiography) is used as the initial screening test for coronary artery aneurysms</li></ul><br />Complications<br /><ul><li><span class=\"concept\" data-cid=\"2892\">coronary artery aneurysm</span></li></ul>",
        "notes_hash": "a97b4351b4c73f3f8311b71311155fcd",
        "knowledge_graph_node_id_link": 1123,
        "concept": "High fever lasting >5 days, red palms with desquamation and strawberry tongue are indicative of Kawasaki disease",
        "concept_percentile": "59",
        "concept_colour": "rgb(209,255,0)",
        "number_attempts": "4670",
        "up_votes": "18",
        "down_votes": "6",
        "column_array": [
            0,
            "161",
            "57",
            "25",
            "137",
            "4289",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/6RpVjF4N8nY\" data-description=\"Kawasaki disease\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"800\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/6RpVjF4N8nY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/6RpVjF4N8nY\" data-description=\"Kawasaki disease\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"800\">Kawasaki disease</a></td></tr><tr><td><span ><small>Khan Academy - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1391\" data-mediaid=\"1391\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1391\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_1391\" data-mediaid=\"1391\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1391\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/EtNI4byIAsI\" data-description=\"Kawasaki disease\" data-upvotes=\"22\" data-downvotes=\"1\" data-media=\"1142\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/EtNI4byIAsI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/EtNI4byIAsI\" data-description=\"Kawasaki disease\" data-upvotes=\"22\" data-downvotes=\"1\" data-media=\"1142\">Kawasaki disease</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1974\" data-mediaid=\"1974\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1974\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">22</span><button type=\"button\" style=\"\" id=\"media_dislike_1974\" data-mediaid=\"1974\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1974\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/zv5UzD2m4Bw\" data-description=\"Kawasaki disease\" data-upvotes=\"11\" data-downvotes=\"2\" data-media=\"37\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/zv5UzD2m4Bw/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/zv5UzD2m4Bw\" data-description=\"Kawasaki disease\" data-upvotes=\"11\" data-downvotes=\"2\" data-media=\"37\">Kawasaki disease</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_66\" data-mediaid=\"66\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_66\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"media_dislike_66\" data-mediaid=\"66\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_66\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "2892": {
                "concept_text": "Coronary artery aneurysms are a complication of Kawasaki disease and this should be screened for with an echocardiogram",
                "concept_percentile": "61"
            },
            "2893": {
                "concept_text": "High dose aspirin is indicated in Kawasaki disease, despite it usually being contraindicated in children",
                "concept_percentile": "88"
            },
            "2894": {
                "concept_text": "High fever lasting >5 days, red palms with desquamation and strawberry tongue are indicative of Kawasaki disease",
                "concept_percentile": "59"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1932",
        "new_question_id": "1716",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "997",
        "notes_id_link": "1_1201",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "CT head",
            "IV bisphosphonate",
            "IV fluids",
            "Broad spectrum antibiotic",
            "IV hydrocortisone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "An 89-year-old man with known metastatic prostate cancer is brought to the emergency department confused. He is unable to give further history but feels generally unwell. On examination his chest is clear, heart sounds normal and his abdomen soft with no tenderness. His initial blood tests are shown below. <br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Na<sup>+</sup></td><td>134 mmol/L</td><td>(135\u2013145)</td></tr><tr><td>K<sup>+</sup></td><td>4.7 mmol/L</td><td>(3.5\u20135.0)</td></tr><tr><td>Urea</td><td>7.8 mmol/L</td><td>(2.5\u20137.8)</td></tr><tr><td>Creatinine</td><td>104 \u00b5mol/L</td><td>(60\u2013110)</td></tr><tr><td>Adjusted Ca<sup>2+</sup></td><td>3.5 mmol/L</td><td>(2.2\u20132.6)</td></tr><tr><td>Mg<sup>2+</sup></td><td>0.81 mmol/L</td><td>(0.7\u20131.0)</td></tr></tbody></table></div><br />What is your first treatment? ",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "Although there may be several causes for his presentation the most likely is malignancy-induced hypercalcaemia. <br /><br />The most common presenting features of which are dehydration, psychiatric manifestations and confusion, anorexia and constipation. Although hypercalcaemia can be secondary to hyperparathyroidism, sarcoidosis, hyperthyroidism, drugs (thiazide diuretics, vitamin D etc) or prolonged immobility etc, 90% of severe cases (>3.0 mmol/l) requiring admission are due to malignancy (as in this gentleman).<br /><br />Treatment involves IV access and requesting appropriate biochemistry, as other electrolytes may be abnormal. Following this chest x-ray and ECG.<br /><br />Fluids resuscitation to replace deficit and maintain hydration often requires large volumes (3-4 litres in the first 24 hours) and this must be the first intervention.<br /><br />If this fails to resolve the hypercalcaemia IV bisphosphonates, such as zoledronate or pamidronate can be used.<br />Following this specific anticancer therapies can be considered.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "An 89-year-old man with known metastatic prostate cancer is brought to the emergency department confused. He is unable to give further history but feels generally unwell. On examination his chest is clear, heart sounds normal and his abdomen soft with no tenderness. His initial blood tests are shown below. <br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Na<sup>+</sup></td><td>134 mmol/L</td><td>(135\u2013145)</td></tr><tr><td>K<sup>+</sup></td><td>4.7 mmol/L</td><td>(3.5\u20135.0)</td></tr><tr><td>Urea</td><td>7.8 mmol/L</td><td>(2.5\u20137.8)</td></tr><tr><td>Creatinine</td><td>104 \u00b5mol/L</td><td>(60\u2013110)</td></tr><tr><td>Adjusted Ca<sup>2+</sup></td><td>3.5 mmol/L</td><td>(2.2\u20132.6)</td></tr><tr><td>Mg<sup>2+</sup></td><td>0.81 mmol/L</td><td>(0.7\u20131.0)</td></tr></tbody></table></div><br />What is your first treatment? ",
        "correct_answer": "3",
        "question_notes": "Although there may be several causes for his presentation the most likely is malignancy-induced hypercalcaemia. <br /><br />The most common presenting features of which are dehydration, psychiatric manifestations and confusion, anorexia and constipation. Although hypercalcaemia can be secondary to hyperparathyroidism, sarcoidosis, hyperthyroidism, drugs (thiazide diuretics, vitamin D etc) or prolonged immobility etc, 90% of severe cases (>3.0 mmol/l) requiring admission are due to malignancy (as in this gentleman).<br /><br />Treatment involves IV access and requesting appropriate biochemistry, as other electrolytes may be abnormal. Following this chest x-ray and ECG.<br /><br />Fluids resuscitation to replace deficit and maintain hydration often requires large volumes (3-4 litres in the first 24 hours) and this must be the first intervention.<br /><br />If this fails to resolve the hypercalcaemia IV bisphosphonates, such as zoledronate or pamidronate can be used.<br />Following this specific anticancer therapies can be considered.",
        "answer_order": "3",
        "answer": "3",
        "title": "Hypercalcaemia: management",
        "body": "The initial management of hypercalcaemia is <span class=\"concept\" data-cid=\"997\">rehydration with normal saline</span>, typically 3-4 litres/day. Following rehydration bisphosphonates may be used. They typically take 2-3 days to work with maximal effect being seen at 7 days<br /><br />Other options include:<br /><ul><li>calcitonin - quicker effect than bisphosphonates</li><li>steroids in sarcoidosis</li></ul><br />Loop diuretics such as furosemide are sometimes used in hypercalcaemia, particularly in patients who cannot tolerate aggressive fluid rehydration. However, they should be used with caution as they may worsen electrolyte derangement and volume depletion.",
        "notes_hash": "2183240d161bf88bdbd4bf3a8956731b",
        "knowledge_graph_node_id_link": 10263,
        "concept": "IV fluid therapy is the first-line management in patients with hypercalcaemia",
        "concept_percentile": "43",
        "concept_colour": "rgb(255,219,0)",
        "number_attempts": "131",
        "up_votes": "24",
        "down_votes": "9",
        "column_array": [
            0,
            "3",
            "14",
            "113",
            "0",
            "1",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Royal College of Physicians</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1326\" data-linkid=\"1326\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1326\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"link_dislike_1326\" data-linkid=\"1326\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1326\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcpjournals.org/content/clinmedicine/17/3/270\">Hypercalcaemia \u00e2\u20ac\u201c presentation and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/630hhyQ-jE0\" data-description=\"Hypercalcemia\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"233\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/630hhyQ-jE0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/630hhyQ-jE0\" data-description=\"Hypercalcemia\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"233\">Hypercalcemia</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_389\" data-mediaid=\"389\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_389\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_389\" data-mediaid=\"389\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_389\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Rs7MwyKZryY\" data-description=\"Hypercalcemia in malignancy\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1144\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Rs7MwyKZryY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Rs7MwyKZryY\" data-description=\"Hypercalcemia in malignancy\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1144\">Hypercalcemia in malignancy</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1979\" data-mediaid=\"1979\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1979\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1979\" data-mediaid=\"1979\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1979\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "997": {
                "concept_text": "IV fluid therapy is the first-line management in patients with hypercalcaemia",
                "concept_percentile": "43"
            }
        },
        "optimisation_reason": ""
    }
]